Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028014 · ClinicalTrials.gov registry record · NA
Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01028014 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 56 participants.
The verdict
NCT01028014, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
Lower urinary tract symptoms such as urinary leakage and overactive bladder affect millions of American women. Women may develop these problems because the innervation of the muscles of the bladder and urethra are injured. Most research on treating these problems has focused on the abnormalities of the bladder muscle, but newer studies have shown abnormalities in the innervation and muscle function of the urethra. Women with these symptoms may benefit from treatment with medications to improve their urethral function. However, to truly understand what types of medications will help women with these symptoms, the investigators wish to study how these medications affect innervation and muscle function in healthy women who do not have lower urinary tract symptoms.
Interventions
- DRUG Cyclobenzaprine
- DRUG Tamsulosin
- DRUG Imipramine
- DRUG Pseudoephedrine
- DRUG Lactose capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01028014
The ClinicalTrials.gov registry entry for NCT01028014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cyclobenzaprine is the first listed.
NCT01028014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01028014 about?
NCT01028014 is a clinical study titled "Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters". Lower urinary tract symptoms such as urinary leakage and overactive bladder affect millions of American women. Women may develop these problems because the innervation of the muscles of the bladder and urethra are injured. Most research on treating these problems has focused on the abnormalities of ...
What is the current status of trial NCT01028014?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2010-04. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01028014?
The interventions under investigation include: Cyclobenzaprine (DRUG), Tamsulosin (DRUG), Imipramine (DRUG), Pseudoephedrine (DRUG), Lactose capsule (DRUG).
Who is sponsoring clinical trial NCT01028014?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.